Additionally, Kir4.1 dysfunction is implicated in epilepsy pathophysiology; its inhibition increases brain-derived neurotrophic factor (BDNF) expression in astrocytes, potentially contributing to epileptogenesis and other neuropsychiatric disorders [30]. Here, BDNF is linked to epilepsy.